[关于α-synuclein在帕金森病针治疗中的作用的研究进展]
Yi-Wei Shen1, Shun Wang2, Yan Bai3
1The Second Clinical Medical School, Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China.
Zhen ci yan jiu = Acupuncture research
|June 24, 2025
概括
帕金森病 (PD) 涉及α-synuclein (α-Syn) 聚合.帕金森病 (PD) 涉及α-synuclein (α-Syn) 聚合.帕金森病 (PD) 涉及α-synuclein (α-Syn) 聚合. 针提供神经保护,通过向PD病原体,包括神经炎症和脑肠轴功能障碍,以抑制α-Syn错误折叠.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 综合医学是一个整体的医学.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其特征是多巴胺能神经元损失.
- 阿尔法-同核素 (α-Syn) 错误折叠和聚合是PD病变的核心.
- PD涉及多种病理途径,包括脑肠轴,线粒体和溶酶体功能障碍.
研究的目的:
- 审查α-Syn在帕金森病发病过程中的作用.
- 探索针对PD的治疗效果.
- 为临床治疗策略提供指导.
主要方法:
- 文献综述专注于PD中的α-Syn.
- 在PD中分析针的机制.
- 综合目前关于PD病原和治疗的研究.
主要成果:
- α-Syn聚合是PD发展的一个关键因素.
- 针在PD模型中显示出神经保护作用.
- 针调节神经炎症和脑肠轴等关键路径.
结论:
- 针可以抑制α-Syn异常折叠和聚合.
- 针为帕金森病提供了一种潜在的治疗方法.
- 了解α-Syn的作用和针的机制可以指导临床实践.
相关概念视频
Neural Regulation
40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722


